JaneMKanowitzMD

Oncology • Waterford, CT

Breast Cancer, Hematologic Oncology

Smilow Cancer Care Center @ Waterford

Join to view full profile

Dr. Kanowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kanowitz's full profile

Already have an account?

Office
Smilow Cancer Care Center Waterford
230 Waterford Pky So
Waterford, CT 06385
Phone+1 860-444-3744
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1990 - 1993
Weill Cornell MedicineClass of 1990

Certifications & Licensure

CT State Medical License 2014 - 2025
NM State Medical License 2012 - 2015
NY State Medical License 1993 - 2013
NJ State Medical License 1995 - 2005
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011

Clinical Trials

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer.
James Laird, Jonathan Leventhal, Jane Kanowitz, Shari Damast> ;Practical Radiation Oncology. 2021 Jun 23
9 citations
Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction
Anne C. Chiang, Jessica Lake, Naralys Sinanis, Debra S. Brandt, Jane Kanowitz, Wajih Zaheer Kidwai, Jeremy S. Kortmansky, Johanna LaSala, Jeffrey Orell, Kert D. Sabbat...> ;Journal of Oncology Practice. 2018 Dec 11
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
Saltz, L. B., Spriggs, D., Schaaf, L. J., Schwartz, G. K., Ilson, D., Kemeny, N., Kanowitz, J., Steger, C., Eng, M., Albanese, P., Semple, D., Hanover, C. K., Elfring,...> ;J Clin Oncol. 1998 Dec
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
Saltz, L. B., Kanowitz, J., Kemeny, N. E., Schaaf, L., Spriggs, D., Staton, B. A., Berkery, R., Steger, C., Eng, M., Dietz, A., Locker, P., Kelsen, D. P.> ;J Clin Oncol. 1996 Nov
Join now to see all

Press Mentions

Yale Cancer Center Study Demonstrates Efficacy of Risk Calculator in Treating Geriatric Patients with CancerSeptember 25th, 2021

Hospital Affiliations

Bristol HealthBristol, Connecticut
Lawrence + Memorial HospitalNew London, Connecticut
Veterans Affairs Connecticut Healthcare SystemWest Haven, Connecticut
Yale-New Haven HospitalNew Haven, Connecticut